Lilly to acquire Stamford biopharma company Loxo Oncology in $8bn deal
Lilly acquisition of Loxo Oncology : US pharma giant Eli Lilly and Company (Lilly) has signed an all-cash deal worth
Continue reading
Tag: Loxo Oncology
Latest Pharma Industry News
-
Spectrum offloads seven hematology/oncology drugs to Acrotech in $300m deal
- FDA accepts X-Rx new drug application for IPD drug X-165
- Tamr joins Accenture’s life sciences ecosystem to help drive innovation in drug discovery and scientific research
-
Clovis PARP inhibitor Rubraca gets EC approval for relapsed ovarian cancer
- Eusa Pharma acquires iMCD drug Sylvant global rights from Janssen
-
Takeda acquisition of Shire : Japanese pharma company completes $62bn acquisition
-
Lilly to acquire Stamford biopharma company Loxo Oncology in $8bn deal
-
US biotech company Celgene to be acquired by Bristol-Myers Squibb for $74bn
-
InventisBio out-licenses lung cancer drug D-0316 to Betta Pharma
- Spectrum seeks ROLONTIS approval for chemotherapy-induced neutropenia
Business News Today
- Entegris to acquire rival chemicals company Versum Materials in $4bn deal
- EDF Renewables acquires 300MW Milligan 1 Wind Project in Nebraska
- Northwestern Medicine and Alfardan Group announce the launch of ‘Alfardan Medical with Northwestern Medicine’
- TomaGold announces the start of drilling at Monster Lake
- Zuckerberg to integrate WhatsApp, Instagram and Facebook Messenger: NYT
- Walmart adds new grocery delivery providers to expand home delivery service
- First Citizens Bank to acquire First South Bancorp for $37.5m
- Hitachi cancels £16bn Wylfa Newydd nuclear power project in UK
- Alibaba’s new hotel runs on robot hospitality
- Hyundai Motor suffers first net loss in 8 years as China sales skid
